Skip to main content
Have a personal or library account? Click to login
Lifelong Management of Right Ventricular Outflow Tract Dysfunction in Adults with Congenital Heart Disease Cover

Lifelong Management of Right Ventricular Outflow Tract Dysfunction in Adults with Congenital Heart Disease

Open Access
|Jun 2026

References

  1. Gurvitz M, Krieger EV, Fuller S, et al. 2025 ACC/AHA/HRS/ISACHD/SCAI Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2025 Dec 18:S0735-1097(25)07763-0. doi: 10.1016/j.jacc.2025.09.006
  2. Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Apr 2;139(14):e698-e800. doi: 10.1161/CIR.0000000000000603 Erratum in: Circulation. 2019 Apr 2;139(14):e833-e834. doi: https://doi.org/10.1161/CIR.0000000000000683
  3. Baumgartner H, De Backer J, Babu-Narayan SV, et al. ESC Scientific Document Group. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. 2021 Feb 11;42(6):563-645. doi: 10.1093/eurheartj/ehaa554
  4. Geva T, Wald RM, Bucholz E, et al. American Heart Association Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Cardiovascular Surgery and Anesthesia; Council on Clinical Cardiology; and Council on Cardiovascular and Stroke Nursing. Long-Term Management of Right Ventricular Outflow Tract Dysfunction in Repaired Tetralogy of Fallot: A Scientific Statement From the American Heart Association. Circulation. 2024 Dec 17;150(25):e689-e707. doi: 10.1161/CIR.0000000000001291
  5. Egidy Assenza G, Krieger EV, Baumgartner H, et al. AHA/ACC vs ESC Guidelines for Management of Adults With Congenital Heart Disease: JACC Guideline Comparison. J Am Coll Cardiol. 2021 Nov 9;78(19):1904-1918. doi: 10.1016/j.jacc.2021.09.010
  6. Villafañe J, Feinstein JA, Jenkins KJ, et al. Adult Congenital and Pediatric Cardiology Section, American College of Cardiology. Hot topics in tetralogy of Fallot. J Am Coll Cardiol. 2013 Dec 10;62(23):2155-2166. doi: 10.1016/j.jacc.2013.07.100
  7. Geva T. Indications for pulmonary valve replacement in repaired tetralogy of fallot: the quest continues. Circulation. 2013 Oct 22;128(17):1855-1857. doi: 10.1161/CIRCULATIONAHA.113.005878
  8. Frigiola A, Hughes M, Turner M, et al. Physiological and phenotypic characteristics of late survivors of tetralogy of fallot repair who are free from pulmonary valve replacement. Circulation. 2013 Oct 22;128(17):1861-1868. doi: 10.1161/CIRCULATIONAHA.113.001600
  9. Lee C, Choi ES, Lee CH. Long-term outcomes of pulmonary valve replacement in patients with repaired tetralogy of Fallot. Eur J Cardiothorac Surg. 2020 Aug 1;58(2):246-252. doi: 10.1093/ejcts/ezaa030
  10. Buechel ER, Dave HH, Kellenberger CJ, et al. Remodelling of the right ventricle after early pulmonary valve replacement in children with repaired tetralogy of Fallot: assessment by cardiovascular magnetic resonance. Eur Heart J. 2005 Dec;26(24):2721-2727. doi: 10.1093/eurheartj/ehi581
  11. Oosterhof T, van Straten A, Vliegen HW, et al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation. 2007 Jul 31;116(5):545-551. doi: 10.1161/CIRCULATIONAHA.106.659664
  12. Vliegen HW, van Straten A, de Roos A, et al. Magnetic resonance imaging to assess the hemodynamic effects of pulmonary valve replacement in adults late after repair of tetralogy of fallot. Circulation. 2002 Sep 24;106(13):1703-1707. doi: 10.1161/01.cir.0000030995.59403.f8
  13. Hoelscher M, Bonassin F, Oxenius A, et al. Right ventricular dilatation in patients with pulmonary regurgitation after repair of tetralogy of Fallot: How fast does it progress? Ann Pediatr Cardiol. 2020 Oct-Dec;13(4):294-300. doi: 10.4103/apc.APC_140_19
  14. Hallbergson A, Gauvreau K, Powell AJ, Geva T. Right ventricular remodeling after pulmonary valve replacement: early gains, late losses. Ann Thorac Surg. 2015 Feb;99(2):660-666. doi: 10.1016/j.athoracsur.2014.09.015
  15. Davlouros PA, Kilner PJ, Hornung TS, et al. Right ventricular function in adults with repaired tetralogy of Fallot assessed with cardiovascular magnetic resonance imaging: detrimental role of right ventricular outflow aneurysms or akinesia and adverse right-to-left ventricular interaction. J Am Coll Cardiol. 2002 Dec 4;40(11):2044-2052. doi: 10.1016/s0735-1097(02)02566-4
  16. Geva T. Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support. J Cardiovasc Magn Reson. 2011 Jan 20;13(1):9. doi: 10.1186/1532-429X-13-9
  17. Gatzoulis MA, Balaji S, Webber SA, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000 Sep 16;356(9234):975-981. doi: 10.1016/S0140-6736(00)02714-8
  18. Geva T, Mulder B, Gauvreau K, et al. Preoperative Predictors of Death and Sustained Ventricular Tachycardia After Pulmonary Valve Replacement in Patients With Repaired Tetralogy of Fallot Enrolled in the INDICATOR Cohort. Circulation. 2018 Nov 6;138(19):2106-2115. doi: 10.1161/CIRCULATIONAHA.118.034740
  19. Harrild DM, Berul CI, Cecchin F, et al. Pulmonary valve replacement in tetralogy of Fallot: impact on survival and ventricular tachycardia. Circulation. 2009 Jan 27;119(3):445-451. doi: 10.1161/CIRCULATIONAHA.108.775221
  20. Khairy P, Aboulhosn J, Gurvitz MZ, et al. Alliance for Adult Research in Congenital Cardiology (AARCC). Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Circulation. 2010 Aug 31;122(9):868-875. doi: 10.1161/CIRCULATIONAHA.109.928481
  21. Bokma JP, Geva T, Sleeper LA, et al. Improved Outcomes After Pulmonary Valve Replacement in Repaired Tetralogy of Fallot. J Am Coll Cardiol. 2023 May 30;81(21):2075-2085. doi: 10.1016/j.jacc.2023.02.052
  22. Waldmann V, Moore JP, Bessière F, et al. Association Between Slowly Conducting Anatomical Isthmuses and Ventricular Tachycardia Inducibility in Tetralogy of Fallot. JACC Clin Electrophysiol. 2026 Jan;12(1):31-40. doi: 10.1016/j.jacep.2025.08.008
  23. Giardini A, Specchia S, Coutsoumbas G, et al. Impact of pulmonary regurgitation and right ventricular dysfunction on oxygen uptake recovery kinetics in repaired tetralogy of Fallot. Eur J Heart Fail. 2006 Nov;8(7):736-743. doi: 10.1016/j.ejheart.2006.01.012
  24. Diller GP, Dimopoulos K, Okonko D, et al. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation. 2005 Aug 9;112(6):828-835. doi: 10.1161/CIRCULATIONAHA.104.529800
  25. Dearani JA, Danielson GK, Puga FJ, et al. Late follow-up of 1095 patients undergoing operation for complex congenital heart disease utilizing pulmonary ventricle to pulmonary artery conduits. Ann Thorac Surg. 2003 Feb;75(2):399-410; discussion 410-1. doi: 10.1016/s0003-4975(02)04547-2
  26. Shinkawa T, Chipman C, Bozzay T, Tang X, Gossett JM, Imamura M. Outcome of right ventricle to pulmonary artery conduit for biventricular repair. Ann Thorac Surg. 2015 Apr;99(4):1357-1366. doi: 10.1016/j.athoracsur.2014.07.095
  27. Mery CM, Guzmán-Pruneda FA, De León LE, et al. Risk factors for development of endocarditis and reintervention in patients undergoing right ventricle to pulmonary artery valved conduit placement. J Thorac Cardiovasc Surg. 2016 Feb;151(2):432-439, 441.e1-2. doi: 10.1016/j.jtcvs.2015.10.069
  28. Thuraisingam A, Skillington P, Ludhani P, et al. Long-term outcomes of right ventricle-to-pulmonary artery conduit insertion in adults with congenital heart disease: survival analysis by National Death Index. Eur J Cardiothorac Surg. 2021 Oct 22;60(4):939-946. doi: 10.1093/ejcts/ezab148
  29. Callahan CP, Jegatheeswaran A, Blackstone EH, at al. Congenital Heart Surgeons’ Society Pulmonary Conduit Working Group. Time-Related Risk of Pulmonary Conduit Re-replacement: A Congenital Heart Surgeons’ Society Study. Ann Thorac Surg. 2022 Feb;113(2):623-629. doi: 10.1016/j.athoracsur.2021.05.024
  30. D’Angelo EC, Egidy Assenza G, Balducci A, et al. Performance and Failure of Right Ventricle to Pulmonary Artery Conduit in Congenital Heart Disease. Am J Cardiol. 2024 Sep 1;226:50-58. doi: 10.1016/j.amjcard.2024.06.026
  31. Beckerman Z, De León LE, Zea-Vera R, Mery CM, Fraser CD Jr. High incidence of late infective endocarditis in bovine jugular vein valved conduits. J Thorac Cardiovasc Surg. 2018 Aug;156(2):728-734.e2. doi: 10.1016/j.jtcvs.2018.03.156
  32. Marathe SP, Hussein N, Wallace FRO, et al. Comparison of homografts and bovine jugular vein conduits in the pulmonary position in patients <20 years of age. J Thorac Cardiovasc Surg. 2022 Sep;164(3):752-762.e8. doi: 10.1016/j.jtcvs.2021.11.087
  33. Sharma A, Cote AT, Hosking MCK, Harris KC. A Systematic Review of Infective Endocarditis in Patients With Bovine Jugular Vein Valves Compared With Other Valve Types. JACC Cardiovasc Interv. 2017 Jul 24;10(14):1449-1458. doi: 10.1016/j.jcin.2017.04.025
  34. Bokma JP, Winter MM, Oosterhof T, et al. Individualised prediction of pulmonary homograft durability in tetralogy of Fallot. Heart. 2015 Nov;101(21):1717-1723. doi: 10.1136/heartjnl-2015-307754
  35. Khanna AD, Hill KD, Pasquali SK, et al. Benchmark Outcomes for Pulmonary Valve Replacement Using The Society of Thoracic Surgeons Databases. Ann Thorac Surg. 2015 Jul;100(1):138-145; discussion 145-146. doi: 10.1016/j.athoracsur.2015.03.025
  36. Bond CJ, Jones TJ, Hoschtitzky JA, Viola N, Danton MHD, Drury NE. Pulmonary Valve Replacement in Adults and Adolescents With Congenital Heart Disease: A United Kingdom and Ireland Survey. Interdiscip Cardiovasc Thorac Surg. 2025 Oct 6;40(10):ivaf214. doi: 10.1093/icvts/ivaf214
  37. Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000 Oct 21;356(9239):1403-1405. doi: 10.1016/S0140-6736(00)02844-0
  38. Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Transcatheter implantation of a bovine valve in pulmonary position: a lamb study. Circulation. 2000 Aug 15;102(7):813-816. doi: 10.1161/01.cir.102.7.813
  39. Matoq A, Shahanavaz S. Transcatheter Pulmonary Valve Outcomes and Mechanisms of Dysfunction. J Clin Med. 2025 Dec 27;15(1):213. doi: 10.3390/jcm15010213
  40. Zahn EM, Hellenbrand WE, Lock JE, McElhinney DB. Implantation of the melody transcatheter pulmonary valve in patients with a dysfunctional right ventricular outflow tract conduit early results from the u.s. Clinical trial. J Am Coll Cardiol. 2009 Oct 27;54(18):1722-1729. doi: 10.1016/j.jacc.2009.06.034
  41. McElhinney DB, Hellenbrand WE, Zahn EM, et al. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial. Circulation. 2010 Aug 3;122(5):507-516. doi: 10.1161/CIRCULATIONAHA.109.921692
  42. McElhinney DB, Cheatham JP, Jones TK, et al. Stent fracture, valve dysfunction, and right ventricular outflow tract reintervention after transcatheter pulmonary valve implantation: patient-related and procedural risk factors in the US Melody Valve Trial. Circ Cardiovasc Interv. 2011 Dec 1;4(6):602-614. doi: 10.1161/CIRCINTERVENTIONS.111.965616
  43. Kenny D, Hijazi ZM, Kar S, et al. Percutaneous implantation of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position: early phase 1 results from an international multicenter clinical trial. J Am Coll Cardiol. 2011 Nov 15;58(21):2248-2256. doi: 10.1016/j.jacc.2011.07.040
  44. Jones TK, McElhinney DB, Vincent JA, et al. Long-Term Outcomes After Melody Transcatheter Pulmonary Valve Replacement in the US Investigational Device Exemption Trial. Circ Cardiovasc Interv. 2022 Jan;15(1):e010852. doi: 10.1161/CIRCINTERVENTIONS.121.010852
  45. Nordmeyer J, Ewert P, Gewillig M, et al. Acute and midterm outcomes of the post-approval MELODY Registry: a multicentre registry of transcatheter pulmonary valve implantation. Eur Heart J. 2019 Jul 14;40(27):2255-2264. doi: 10.1093/eurheartj/ehz201
  46. Kenny D, Rhodes JF, Fleming GA, et al. 3-Year Outcomes of the Edwards SAPIEN Transcatheter Heart Valve for Conduit Failure in the Pulmonary Position From the COMPASSION Multicenter Clinical Trial. JACC Cardiovasc Interv. 2018 Oct 8;11(19):1920-1929. doi: 10.1016/j.jcin.2018.06.001
  47. Lim DS, Kim D, Aboulhosn J, et al. Congenital Pulmonic Valve Dysfunction Treated With SAPIEN 3 Transcatheter Heart Valve (from the COMPASSION S3 Trial). Am J Cardiol. 2023 Mar 1;190:102-109. doi: 10.1016/j.amjcard.2022.12.010
  48. McElhinney DB, Zhang Y, Levi DS, et al. Reintervention and Survival After Transcatheter Pulmonary Valve Replacement. J Am Coll Cardiol. 2022 Jan 4;79(1):18-32. doi: 10.1016/j.jacc.2021.10.031
  49. Stefanescu Schmidt AC, Armstrong AK, Aboulhosn JA, et al. Transcatheter Pulmonary Valve Replacement With Balloon-Expandable Valves: Utilization and Procedural Outcomes From the IMPACT Registry. JACC Cardiovasc Interv. 2024 Jan 22;17(2):231-244. doi: 10.1016/j.jcin.2023.10.065
  50. Morray BH, McElhinney DB, Cheatham JP, et al. Risk of coronary artery compression among patients referred for transcatheter pulmonary valve implantation: a multicenter experience. Circ Cardiovasc Interv. 2013 Oct 1;6(5):535-542. doi: 10.1161/CIRCINTERVENTIONS.113.000202
  51. Fraisse A, Assaidi A, Mauri L, et al. Coronary artery compression during intention to treat right ventricle outflow with percutaneous pulmonary valve implantation: incidence, diagnosis, and outcome. Catheter Cardiovasc Interv. 2014 Jun 1;83(7):E260-E268. doi: 10.1002/ccd.25471
  52. Bergersen L, Benson LN, Gillespie MJ, et al. Harmony Feasibility Trial: Acute and Short-Term Outcomes With a Self-Expanding Transcatheter Pulmonary Valve. JACC Cardiovasc Interv. 2017 Sep 11;10(17):1763-1773. doi: 10.1016/j.jcin.2017.05.034
  53. Góreczny S, Lazu M, Gewillig M, et al. Early Outcomes of Self-expanding VenusP-valve Implantation in Dysfunctional Right Ventricular Outflow Tracts in Pediatric Patients: A Single-Center Evolving Experience. Pediatr Cardiol. 2025 Oct 9. doi: 10.1007/s00246-025-04048-4
  54. Goldstein BH, McElhinney DB, Gillespie MJ, et al. Early Outcomes From a Multicenter Transcatheter Self-Expanding Pulmonary Valve Replacement Registry. J Am Coll Cardiol. 2024 Apr 9;83(14):1310-1321. doi: 10.1016/j.jacc.2024.02.010
  55. Morray BH, Gillespie MJ, Cheatham JP, et al. Midterm Outcomes in a Pooled Cohort of Harmony Transcatheter Pulmonary Valve Recipients. Circ Cardiovasc Interv. 2025 Sep;18(9):e015196. doi: 10.1161/CIRCINTERVENTIONS.125.015196
  56. Qureshi SA, Jones MI, Pushparajah K, et al. Transcatheter Pulmonary Valve Implantation Using Self-Expandable Percutaneous Pulmonary Valve System: 3-Year CE Study Results. JACC Cardiovasc Interv. 2025 Apr 28;18(8):1045-1056. doi: 10.1016/j.jcin.2024.12.031
  57. Dimas VV, Babaliaros V, Kim D, et al. Multicenter Pivotal Study of the Alterra Adaptive Prestent for the Treatment of Pulmonary Regurgitation. JACC Cardiovasc Interv. 2024 Oct 14;17(19):2287-2297. doi: 10.1016/j.jcin.2024.07.036
  58. McElhinney DB, Benson LN, Eicken A, Kreutzer J, Padera RF, Zahn EM. Infective endocarditis after transcatheter pulmonary valve replacement using the Melody valve: combined results of 3 prospective North American and European studies. Circ Cardiovasc Interv. 2013 Jun;6(3):292-300. doi: 10.1161/CIRCINTERVENTIONS.112.000087
  59. McElhinney DB, Sondergaard L, Armstrong AK, et al. Endocarditis After Transcatheter Pulmonary Valve Replacement. J Am Coll Cardiol. 2018 Dec 4;72(22):2717-2728. doi: 10.1016/j.jacc.2018.09.039
  60. McElhinney DB, Zhang Y, Aboulhosn JA, et al. Multicenter Study of Endocarditis After Transcatheter Pulmonary Valve Replacement. J Am Coll Cardiol. 2021 Aug 10;78(6):575-589. doi: 10.1016/j.jacc.2021.05.044
  61. Buddhe S, Maskatia SA, Jaggi A, Haeffele C, Chan FP, McElhinney DB. Device-Related Findings on Computed Tomography After Transcatheter Pulmonary Valve Replacement With the Harmony Valve. Circ Cardiovasc Interv. 2025 Nov;18(11):e015186. doi: 10.1161/CIRCINTERVENTIONS.125.015186
  62. Sefton C, Firth A, Curran K, et al. Outcomes of Hypoattenuating Leaflet Thickening Post-Transcatheter Pulmonary Valve Replacement. JACC Adv. 2025 Mar;4(3):101599. doi: 10.1016/j.jacadv.2025.101599
  63. Waldmann V, Bessière F, Gardey K, et al. Systematic Electrophysiological Study Prior to Pulmonary Valve Replacement in Tetralogy of Fallot: A Prospective Multicenter Study. Circ Arrhythm Electrophysiol. 2023 Jun;16(6):e011745. doi: 10.1161/CIRCEP.122.011745
  64. Taylor A, Yang J, Dubin A, et al. Ventricular arrhythmias following transcatheter pulmonary valve replacement with the harmony TPV25 device. Catheter Cardiovasc Interv. 2022 Nov;100(5):766-773. doi: 10.1002/ccd.30393
  65. Moore JP, Ghantous E, Waldmann V, et al. Clinical and Electrophysiological Characteristics of Inducible Polymorphic Ventricular Tachycardia in Repaired Tetralogy of Fallot. JACC Clin Electrophysiol. 2025 Aug;11(8):1807-1816. doi: 10.1016/j.jacep.2025.04.016
  66. Georgiev S, Ewert P, Eicken A, et al. Munich Comparative Study: Prospective Long-Term Outcome of the Transcatheter Melody Valve Versus Surgical Pulmonary Bioprosthesis With Up to 12 Years of Follow-Up. Circ Cardiovasc Interv. 2020 Jul;13(7):e008963. doi: 10.1161/CIRCINTERVENTIONS.119.008963
  67. Ribeiro JM, Teixeira R, Lopes J, Costa M, Pires A, Gonçalves L. Transcatheter Versus Surgical Pulmonary Valve Replacement: A Systemic Review and Meta-Analysis. Ann Thorac Surg. 2020 Nov;110(5):1751-1761. doi: 10.1016/j.athoracsur.2020.03.007
DOI: https://doi.org/10.14797/mdcvj.1797 | Journal eISSN: 1947-6108
Language: English
Page range: 67 - 77
Submitted on: Feb 9, 2026
Accepted on: May 21, 2026
Published on: Jun 30, 2026
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services

© 2026 Maurizio Brighenti, Gabriele Egidy Assenza, Elisabetta Mariucci, Andrea Donti, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.